Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Mar 5, 2024
- Accession no.
- 0001415889-24-006846
- Filed
- Mar 5, 2024
- Trade date
- Mar 1, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $28.1K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001415889-24-007234 (Mar 7, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | SSaleDisposed | −428 | $9.06 | −$3,877.68 | 242,621 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −753 | $9.06 | −$6,822.18 | 241,868 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −1,916 | $9.06 | −$17,358.96 | 239,952 | Direct | |
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +34,500 | $0.00 | $0 | 274,452 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +69,100 | $0.00 | $0 | 69,100 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.